Oral Answers to Questions

Debate between Emma Reynolds and Matt Hancock

Tuesday 27th November 2018 Commons Chamber

[Emma Reynolds (Wolverhampton North East) (Lab)]

20. What assessment he has made of the effect of the UK leaving the EU on the ability of the NHS to access medicines and medical equipment.

[The Secretary of State for Health and Social Care (Matt Hancock)]

The deal that the Prime Minister struck to leave the EU will ensure access to medicines and medical equipment, so it is another good reason to vote for the deal.

--- Later in debate ---

[Emma Reynolds]

We are currently an influential member of the European Medicines Agency, which gives patients access to new medicines six months sooner than non-members. Given that the political declaration reduces us to exploring the possibility of co-operation with the EMA, will the Secretary of State admit that there are no guarantees for patients and that it is very likely that they will have to wait longer?

[Matt Hancock]

No, because in the event, under any circumstances, we will make sure that there are no further burdens on ensuring that medicines can get licensed here so that patients can use them, but it is another reason why the hon. Lady should vote for the deal.

Oral Answers to Questions

Debate between Emma Reynolds and Matt Hancock

Tuesday 23rd October 2018 Commons Chamber

[Matt Hancock]

My right hon. Friend is an assiduous supporter of his constituents. I look forward very much to taking up his invitation to visit. I have looked into some of the details of the proposal on the table and, indeed, at some of the other proposals that may benefit the Hillingdon area. I look forward to discussing them with him.

[Emma Reynolds (Wolverhampton North East) (Lab)]

T9. I welcome Baroness Cumberlege’s ongoing review of the impact of the use of Primodos pregnancy tests, but for the families affected to have confidence in this review they must be given sufficient time to give evidence. Will the Health Secretary ensure that that happens?